Priority Date: 21.06.12 (US 201261662746P)

OLIGONUCLEOTIDE-BASED INHIBITORS COMPRISING LOCKED NUCLEIC ACID MOTIF

  • Application ID: EP13807536
  • Status: EXAMINATION IN PROGRESS

Attorney

operating since 1890
Headquarter in London and 4 offices
active in Legal Services

Specialization

This patent has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING) Mewburn Ellis LLP is specialized in the combination A61 and C12. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Sperling Fischer & Heyner, Zacco Denmark A/S, Lederer Keller Patentanwälte Partnerschaft mbB and 173 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 21.06.2012 - Priority Date (US 201261662746P)
  • 27.12.2013 - Publication A2 (WO2013192576)
  • 29.04.2015 - Publication A2 (EP2864482)

IPC Classification